Fundamental Analysis
70 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +18.5% | +115.3% | 3 / 3 | -1.6% | +2.12 pp | +1.09 pp | +23.7% | 0.32 | 10.70 | 325 | −1,6% | 20,9 | +18,5% | 10.70 | 15.10 | −29,1% |
| Pts | 0 | 12 | 12 | 0 | 8 | 8 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 51.000 (close price on 2026-10-19)EPS (TTM): 4.767
Financial charts
1.Revenue & growth
VND bn325Q2/26
1.Revenue & growth
VND bn325Q2/26
2.Profit & growth
VND bn21,0Q2/26
3.Profit mix (Penman)
VND bn77,8Q2/26
4.Margins & cost structure
%17.1%Q2/26
5.Returns & cash cycle
% · days29.3%Q2/26
6.Earnings quality & cash
VND bn63,6Q2/26
7.Asset structure
VND bn559Q2/26
8.Funding & debt health
VND bn · times559Q2/26
9.Revenue backlog
VND bn2,07Q2/26
10.Valuation
times · %10,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.615Q2/26
Adjusted EPS growth, latest quarter
19.0%
Average adjusted EPS growth, 3 quarters
115%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26